The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies

1. Lin, L.
2. Sabnis, A.J.
3. Chan, E.
4. Olivas, V.
5. Cade, L.
6. Pazarentzos, E.
7. Asthana, S.
8. Neel, D.
9. Yan, J.J.
10. Lu, X.
11. Pham, L.
12. Wang, M.M.
13. Karachaliou, N.
14. Cao, M.G.
15. Manzano, J.L.
16. Ramirez, J.L.
17. Torres, J.M.S.
18. Buttitta, F.
19. Rudin, C.M.
20. Collisson, E.A.
21. Algazi, A.
22. Robinson, E.
23. Osman, I.
24. Muñoz-Couselo, E.
25. Cortes, J.
26. Frederick, D.T.
27. Cooper, Z.A.
28. Mcmahon, M.
29. Marchetti, A.
30. Rosell, R.
31. Flaherty, K.T.
32. Wargo, J.A.
33. Bivona, T.G.
34. Mostrar todos los/as autores/as +